Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Peden

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Topics in Microbiology and Immunology|July 9, 2020
Regulatory Considerations on the Development of mRNA VaccinesRamachandra Naik, Keith Peden
Vaccine|November 10, 2015
RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cellsXiao Wang, Keith Peden, Haruhiko Murata
Biochimica Et Biophysica Acta|July 23, 2003
HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitorsMarina Zaitseva, Keith Peden, Hana Golding
Virology|October 16, 2007
Identification of a mutation in the SV40 capsid protein VP1 that influences plaque morphology, vacuolization, and receptor usageHaruhiko Murata, Keith Peden, Andrew M Lewis
Biologicals : Journal of the International Association of Biological Standardization|March 17, 2009
Issues associated with residual cell-substrate DNA in viral vaccinesLi Sheng-Fowler, Andrew M Lewis, Keith Peden
Biologicals : Journal of the International Association of Biological Standardization|May 22, 2009
Quantitative determination of the infectivity of the proviral DNA of a retrovirus in vitro: Evaluation of methods for DNA inactivationLi Sheng-Fowler, Andrew M Lewis, Keith Peden
Plos One|February 26, 2013
Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCRBelete Teferedegne, Andrew M Lewis, Keith Peden, et al.
Vaccine|March 1, 2011
Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seedsHaruhiko Murata, Juliete Macauley, Andrew M Lewis, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 16, 2007
Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude miceManu Manohar, Brian Orrison, Keith Peden, et al.
Journal of Virological Methods|September 5, 2009
A quantitative PCR assay for SV40 neutralization adaptable for high-throughput applicationsHaruhiko Murata, Belete Teferedegne, Andrew M Lewis, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Topics in Microbiology and Immunology|July 9, 2020
Regulatory Considerations on the Development of mRNA VaccinesRamachandra Naik, Keith Peden
Vaccine|November 10, 2015
RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cellsXiao Wang, Keith Peden, Haruhiko Murata
Biochimica Et Biophysica Acta|July 23, 2003
HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitorsMarina Zaitseva, Keith Peden, Hana Golding
Virology|October 16, 2007
Identification of a mutation in the SV40 capsid protein VP1 that influences plaque morphology, vacuolization, and receptor usageHaruhiko Murata, Keith Peden, Andrew M Lewis
Biologicals : Journal of the International Association of Biological Standardization|March 17, 2009
Issues associated with residual cell-substrate DNA in viral vaccinesLi Sheng-Fowler, Andrew M Lewis, Keith Peden
Biologicals : Journal of the International Association of Biological Standardization|May 22, 2009
Quantitative determination of the infectivity of the proviral DNA of a retrovirus in vitro: Evaluation of methods for DNA inactivationLi Sheng-Fowler, Andrew M Lewis, Keith Peden
Plos One|February 26, 2013
Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCRBelete Teferedegne, Andrew M Lewis, Keith Peden, et al.
Vaccine|March 1, 2011
Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seedsHaruhiko Murata, Juliete Macauley, Andrew M Lewis, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 16, 2007
Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude miceManu Manohar, Brian Orrison, Keith Peden, et al.
Journal of Virological Methods|September 5, 2009
A quantitative PCR assay for SV40 neutralization adaptable for high-throughput applicationsHaruhiko Murata, Belete Teferedegne, Andrew M Lewis, et al.
Pageof 4